Your browser doesn't support javascript.
loading
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma.
Budczies, Jan; Kirchner, Martina; Kluck, Klaus; Kazdal, Daniel; Glade, Julia; Allgäuer, Michael; Kriegsmann, Mark; Heußel, Claus-Peter; Herth, Felix J; Winter, Hauke; Meister, Michael; Muley, Thomas; Fröhling, Stefan; Peters, Solange; Seliger, Barbara; Schirmacher, Peter; Thomas, Michael; Christopoulos, Petros; Stenzinger, Albrecht.
Afiliação
  • Budczies J; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kirchner M; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kluck K; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kazdal D; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Glade J; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Allgäuer M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kriegsmann M; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
  • Heußel CP; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Herth FJ; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Winter H; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Meister M; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
  • Muley T; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
  • Fröhling S; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
  • Peters S; Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Seliger B; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
  • Schirmacher P; Department of Pneumology, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
  • Thomas M; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
  • Christopoulos P; Department of Thoracic Surgery, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
  • Stenzinger A; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
Oncoimmunology ; 10(1): 1860586, 2021 01 11.
Article em En | MEDLINE | ID: mdl-33520406
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha